source:[1] Massive Debt-Fueled Deals Are Back on Wall Street - The Wall Street Journal (https://www.wsj.com/finance/investing/massive ...)[2] Pfizer Is Not a Done Dealmaker After Metsera Buy, With $6B More To Spend - BioSpace (https://www.biospace.com/business/pfizer-is-n ...)[3] Medline’s Blockbuster IPO–And Its Billionaire Founding Family - Forbes (https://www.forbes.com/sites/innovationrx/202 ...)